• Molecular NameBromopride
  • SynonymNA
  • Weight344.253
  • Drugbank_IDN/A
  • ACS_NO4093-35-0
  • Show 3D model
  • LogP (experiment)2.83
  • LogP (predicted, AB/LogP v2.0)2.65
  • pkaN/A
  • LogD (pH=7, predicted)0.47
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-0.42
  • LogSw (predicted, AB/LogsW2.0)1.4
  • Sw (mg/ml) (predicted, ACD/Labs)0.86
  • No.of HBond Donors3
  • No.of HBond Acceptors5
  • No.of Rotatable Bonds7
  • TPSA67.59
  • StatusClinical trial
  • AdministrationOral, IM, IV
  • PharmacologyA dopamine antagonist with prokinetic properties widely used as an antiemetic, closely related to metoclopramide.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability67.5
  • Protein binding40.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic
  • Half life4 to 5 h
  • ExcretionRenal, 10 to 14% unchanged
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A